{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:14:50Z","timestamp":1790234090118,"version":"4.1.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2011,6,30]],"date-time":"2011-06-30T00:00:00Z","timestamp":1309392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0020967","type":"journal-article","created":{"date-parts":[[2011,6,30]],"date-time":"2011-06-30T16:54:22Z","timestamp":1309452862000},"page":"e20967","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":63,"title":["Improved Survival of HIV-1-Infected Patients with Progressive Multifocal Leukoencephalopathy Receiving Early 5-Drug Combination Antiretroviral Therapy"],"prefix":"10.1371","volume":"6","clinical-trial-number":[{"clinical-trial-number":"nct00120367","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Jacques","family":"Gasnault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Costagliola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houria","family":"Hendel-Chavez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Dulioust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Pakianather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Aur\u00e9lie","family":"Mazet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Ghislaine","family":"de Goer de Herve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Lancar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Lascaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydie","family":"Porte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Delfraissy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yassine","family":"Taoufik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the ANRS 125 Trial Team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,6,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/13550280152537193","article-title":"Epidemiological evidence and molecular basis of interactions between HIV and JC virus.","volume":"7","author":"JR Berger","year":"2001","journal-title":"J Neurovirol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/ana.10827","article-title":"Changing incidence of central nervous system diseases in the EuroSIDA cohort.","volume":"55","author":"A d'Arminio Monforte","year":"2004","journal-title":"Ann Neurol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1086\/595299","article-title":"Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study.","volume":"199","author":"FN Engsig","year":"2009","journal-title":"J Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1468-1293.2008.00554.x","article-title":"Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy.","volume":"9","author":"S Grabar","year":"2008","journal-title":"HIV Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1086\/597468","article-title":"Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal.","volume":"48","author":"A Mocroft","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1093\/brain\/awh215","article-title":"A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.","volume":"127","author":"RA Du Pasquier","year":"2004","journal-title":"Brain"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1084\/jem.20031947","article-title":"Progress in defining CD4 helper cell responses in chronic viral infections.","volume":"198","author":"CL Day","year":"2003","journal-title":"J Exp Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/00002030-200307040-00004","article-title":"Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy.","volume":"17","author":"J Gasnault","year":"2003","journal-title":"AIDS"},{"key":"ref9","first-page":"43","article-title":"[New trends in progressive multifocal leukoencephalopathy].","volume":"162","author":"J Gasnault","year":"2006","journal-title":"Rev Neurol (Paris)"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1056\/NEJM199809173391216","article-title":"Progressive multifocal leukoencephalopathy, HIV, and highly active antiretroviral therapy.","volume":"339","author":"P Cinque","year":"1998","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1212\/WNL.52.3.623","article-title":"HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy.","volume":"52","author":"DB Clifford","year":"1999","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3109\/13550289909029483","article-title":"Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy.","volume":"5","author":"J Gasnault","year":"1999","journal-title":"J Neurovirol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1086\/315817","article-title":"The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy.","volume":"182","author":"A De Luca","year":"2000","journal-title":"J Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/13550280390195388","article-title":"Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA).","volume":"9","author":"A Antinori","year":"2003","journal-title":"J Neurovirol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1097\/QAD.0b013e32830a5043","article-title":"Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis.","volume":"22","author":"A De Luca","year":"2008","journal-title":"AIDS"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/135965350601100110","article-title":"Increased antiretroviral potency by the addition of enfuvirtide to a four-drug regimen in antiretroviral-naive, HIV-infected patients.","volume":"11","author":"J Molto","year":"2006","journal-title":"Antivir Ther"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1086\/500206","article-title":"Week-12 response to therapy as a predictor of week 24, 48, and 96 outcome in patients receiving the HIV fusion inhibitor enfuvirtide in the T-20 versus Optimized Regimen Only (TORO) trials.","volume":"42","author":"F Raffi","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1089\/apc.2006.0174","article-title":"TORO: ninety-six-week virologic and immunologic response and safety evaluation of enfuvirtide with an optimized background of antiretrovirals.","volume":"21","author":"J Reynes","year":"2007","journal-title":"AIDS Patient Care STDS"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/13550280152537247","article-title":"The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy.","volume":"7","author":"P Cinque","year":"2001","journal-title":"J Neurovirol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/13550280390195298","article-title":"The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: defining a consensus terminology.","volume":"9","author":"P Cinque","year":"2003","journal-title":"J Neurovirol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","article-title":"Interobserver agreement for the assessment of handicap in stroke patients.","volume":"19","author":"JC van Swieten","year":"1988","journal-title":"Stroke"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/01.STR.20.7.864","article-title":"Measurements of acute cerebral infarction: a clinical examination scale.","volume":"20","author":"T Brott","year":"1989","journal-title":"Stroke"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1399-3046.2004.00211.x","article-title":"Polyomavirus infection in pediatric renal transplant recipients: evaluation using a quantitative real-time PCR technique.","volume":"8","author":"J Herman","year":"2004","journal-title":"Pediatr Transplant"},{"issue":"2","key":"ref24","first-page":"45","article-title":"Neurologic complications of HIV disease and their treatment.","volume":"18","author":"SL Letendre","year":"2010","journal-title":"Top HIV Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/QAI.0b013e31817bec64","article-title":"Influence of HAART on the clinical course of HIV-1-infected patients with progressive multifocal leukoencephalopathy: results of an observational multicenter study.","volume":"49","author":"V Falco","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1212\/01.wnl.0000343510.08643.74","article-title":"PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids.","volume":"72","author":"K Tan","year":"2009","journal-title":"Neurology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00401-005-0983-y","article-title":"Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy.","volume":"109","author":"A Vendrely","year":"2005","journal-title":"Acta Neuropathol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1086\/314496","article-title":"Prognostic value of JC virus load in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy.","volume":"178","author":"Y Taoufik","year":"1998","journal-title":"J Infect Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1073\/pnas.87.9.3479","article-title":"Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells.","volume":"87","author":"H Tada","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.","volume":"401","author":"F Sallusto","year":"1999","journal-title":"Nature"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1084\/jem.20031598","article-title":"HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity.","volume":"198","author":"SA Younes","year":"2003","journal-title":"J Exp Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.4049\/jimmunol.181.9.5974","article-title":"Heterospecific CD4 help to rescue CD8 T cell killers.","volume":"181","author":"MG de Goer de Herve","year":"2008","journal-title":"J Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev.immunol.25.022106.141548","article-title":"Effector and memory CTL differentiation.","volume":"25","author":"MA Williams","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4049\/jimmunol.168.1.499","article-title":"Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope.","volume":"168","author":"IJ Koralnik","year":"2002","journal-title":"J Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1128\/JVI.01809-06","article-title":"Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy.","volume":"81","author":"MA Lima","year":"2007","journal-title":"J Virol"},{"key":"ref36","first-page":"997","article-title":"Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment.","volume":"119","author":"Y Levy","year":"2009","journal-title":"J Clin Invest"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0020967","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T18:22:45Z","timestamp":1686162165000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0020967"}},"subtitle":[],"editor":[{"given":"Rupert","family":"Kaul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,6,30]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,6,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0020967","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,30]]}}}